|
Product Detail :
|
Preliminary Market Consultation Rental For A Period Of 60 Months Of A Robotic System For The Preparation Of Antiblastic Drugs
|
| Tender Detail : |
Buyer profile: Preliminary market consultation rental for a period of 60 months of a robotic system for the preparation of antiblastic drugs
Name and address of the contracting authorityhospital policlinico san martino – largo rosanna benzi, 10 – 16132 genovaobject: preliminary market consultation aimed at the possible acquisition through rental for a duration of 60 months, through a negotiated procedure without prior publication of a tender notice, pursuant to art. . 76 paragraph 2 letter. b of the legislative decree 31 March 2023 n. 36, of a robotic apothecachemo system for the preparation of antiblastic drugs. Reason for publication: with this notice it is intended to launch a preliminary market consultation in order to find out whether, differently from the information in possession of this contracting authority, other economic operators in addition to the company aea s.r.l. have solutions that comply in an equivalent manner with the technical and performance requirements of the requested system, in particular: general characteristics of the requested instrumentation: - guarantee of a class A processing in line with GMP standards, which can be inserted in a class D environment superior - ability to prepare a minimum of 80 preparations/day - ability to work per patient and not just per product line - guided insertion of all the components of the preparation with the ability to recognize them both with barcode and by image acquired with a video camera and by weight of the drug (total: container + product) guaranteeing total traceability and reduction of error given by the subjectivity of the operator - ability to empty the bag of the necessary volume set by the pharmacist automatically - use of 100 ml / 250 solvent bags ml / 500 ml and 1000 ml, syringes and elastomers - ability to constantly implement the workable drugs whether they are new active ingredients or different purchased medicinal specialties - ability to interface with the tera 80 prescriptive system supplied at the antiblastic laboratory - ability to manage the drug residues deriving from preparations already carried out and possibility of calculating the real nominal volume of the vials (overfilling) - ability to reconstruct the powders, tracing their processing and using them subsequently for the preparations - traceability of each individual preparation with reports with % error - continuous assistance from the company remotely and in case of failure to resolve the problem on-site verification included in the rental fee - self-failure of the therapy (with notification to the operator) in case of error percentage out of range. name and address of the the economic operator in whose favor the acquisition is envisaged: aea s.r.l., via fiore, 16 – 60030 angeli di rosora (an)
|